Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$0.14 - $0.39 $171,753 - $478,455
-1,226,809 Reduced 77.5%
356,270 $71,000
Q3 2023

Nov 13, 2023

BUY
$0.34 - $1.23 $538,246 - $1.95 Million
1,583,079 New
1,583,079 $585,000

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0

About Better Therapeutics, Inc.


  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track This Portfolio

Track Mmcap International Inc. Spc Portfolio

Follow Mmcap International Inc. Spc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mmcap International Inc. Spc, based on Form 13F filings with the SEC.

News

Stay updated on Mmcap International Inc. Spc with notifications on news.